Plum; Lori A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Plum; Lori A..The latest application filed is for "once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration".

Company Profile

8.120.123

Plum; Lori A. - Arena WI
Plum; Lori A - Arena WI
Plum; Lori A. - Madison WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of homosalate and octyl salicylate to treat multiple sclerosis Grant 11,266,664 - DeLuca , et al. March 8, 2	2022-03-08
Once-a-Week Administration of 25-Hydroxy Vitamin D3 to Sustain Elevated Steady-State Pharmacokinetic Blood Concentration App 20200281947 - DeLuca; Hector F. ; et al.	2020-09-10
Use Of 2amd And 2md To Treat Fibrosis App 20200061084 - DeLuca; Hector F. ; et al.	2020-02-27
Use Of Homosalate And Octyl Salicylate To Treat Multiple Sclerosis App 20190381075 - DeLuca; Hector F. ; et al.	2019-12-19
(20S)-1-.alpha.,25-dihydroxy-24,24-difluoro-19-nor-vitamin D.sub.3 analogs and their pharmaceutical uses Grant 10,494,337 - DeLuca , et al. De	2019-12-03
2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs Grant 10,479,764 - DeLuca , et al. Nov	2019-11-19
Use of homosalate and octyl salicylate to treat multiple sclerosis Grant 10,434,110 - DeLuca , et al. O	2019-10-08
Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism Grant 10,369,161 - DeLuca , et al.	2019-08-06
Combination of low dose 2-methylene-19-nor-(20S)1.alpha., 25-dihydroxyvitamin D.sub.3 and calcimimetics to treat secondary hyperparathyroidism Grant 10,105,375 - DeLuca , et al. October 23, 2	2018-10-23
Use of 2-methylene-19-nor-(20S)-1.alpha.,25-Dihydroxyvitamin D.sub.3 to treat and prevent secondary hyperparathyroidism in a subject having renal failure Grant 10,046,000 - DeLuca , et al. August 14, 2	2018-08-14
Combination Of Low Dose 2-methylene-19-nor-(20s)-1alpha, 25-dihydroxyvitamin D3 And Calcimimetics To Treat Secondary Hyperparathyroidism App 20180055856 - DeLuca; Hector F. ; et al.	2018-03-01
Use Of Homosalate And Octyl Salicylate To Treat Multiple Sclerosis App 20180015107 - DeLuca; Hector F. ; et al.	2018-01-18
Methods Of Use To Orally And Topically Treat Acne And Other Skin Conditions By Administering A 19-nor Containing Vitamin D Analog With Or Without A Retinoid App 20170326159 - Clagett-Dame; Margaret ; et al.	2017-11-16
Use of 2-methylene-19-nor-(20S)-1.alpha.,25-dihydroxyvitamin D.sub.3 and calcimimetics to treat secondary hyperparathyroidism Grant 9,814,736 - DeLuca , et al. November 14, 2	2017-11-14
Use Of 2amd And 2md To Treat Fibrosis App 20170296558 - DeLuca; Hector F. ; et al.	2017-10-19
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism App 20170252360 - DeLuca; Hector F. ; et al.	2017-09-07
Synthesis And Biological Activity Of 2-methylene Analogs Of Calcitriol And Related Compounds App 20170253546 - DeLuca; Hector F. ; et al.	2017-09-07
Use of 2-methylene-19-nor-(20S)-1.alpha.,25-dihydroxyvitamin D3 to prevent secondary hyperparathyroidism or the symptoms thereof Grant 9,717,744 - DeLuca , et al. August 1, 2	2017-08-01
Synthesis and biological activity of 2-methylene analogs of calcitriol and related compounds Grant 9,688,596 - DeLuca , et al. June 27, 2	2017-06-27
Use Of 2-methylene-19-nor-(20s)-1alpha,25-dihydroxyvitamin D3 To Treat Secondary Hyperparathyroidism In Patients Previously Treated With Calcimimetics App 20170042913 - DeLuca; Hector F. ; et al.	2017-02-16
Synthesis And Biological Activity Of 2-methylene Analogs Of Calcitriol And Related Compounds App 20170036977 - DeLuca; Hector F. ; et al.	2017-02-09
Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics Grant 9,539,264 - DeLuca , et al. January 10, 2	2017-01-10
1-alpha,25-dihydroxy-24,24-difluoro-19-nor-vitamin D3 Analogs And Theirpharmaceutical Uses App 20160347710 - DeLuca; Hector F. ; et al.	2016-12-01
Methods Of Use To Orally And Topically Treat Acne And Other Skin Conditions By Administering A 19-nor Containing Vitamin D Analog With Or Without A Retinoid App 20160235770 - Clagett-Dame; Margaret ; et al.	2016-08-18
(22E)-2-methylene-22-dehydro-1.alpha.,24,25-trihydroxy-19-nor-vitamin D.sub.3 analogs Grant 9,416,102 - DeLuca , et al. August 16, 2	2016-08-16
Use Of 2-methylene-19-nor-(20s)-1-alpha,25-dihydroxyvitamin D3 To Treat Secondary Hyperparathyroidism In Patients Previously Treated With Calcimimetics App 20160184328 - DeLuca; Hector F. ; et al.	2016-06-30
Use Of 2-methylene-19-nor-(20s)-1-alpha,25-dihydroxyvitamin D3 To Treat Primary Hyperparathyroidism App 20160184327 - DeLuca; Hector F. ; et al.	2016-06-30
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism App 20160136184 - DeLuca; Hector F. ; et al.	2016-05-19
Methods of use to orally and topically treat acne and other skin conditions by administering a 19-nor containing vitamin D analog with or without a retinoid Grant 9,339,509 - Clagett-Dame , et al. May 17, 2	2016-05-17
(20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D.sub.3 analogs and their uses Grant 9,290,447 - DeLuca , et al. March 22, 2	2016-03-22
Once-a-Week Administration of 25-Hydroxy Vitamin D3 to Sustain Elevated Steady-State Pharmacokinetic Blood Concentration App 20150374722 - DeLuca; Hector F. ; et al.	2015-12-31
Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1.alpha.,25-dihydroxyvitamin D.sub.3 and related precursors Grant 9,212,137 - DeLuca , et al. December 15, 2	2015-12-15
Use of 2-methylene-19-nor-(20S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to treat secondary hyperparathyroidism Grant 9,205,096 - DeLuca , et al. December 8, 2	2015-12-08
Use of 2-methylene-19-nor-(20S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to treat secondary hyperparathyroidism Grant 9,034,853 - DeLuca , et al. May 19, 2	2015-05-19
3-desoxy-2-methylene-19-nor-vitamin D analogs and their uses Grant 8,993,547 - DeLuca , et al. March 31, 2	2015-03-31
N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses Grant 8,987,235 - DeLuca , et al. March 24, 2	2015-03-24
(22e)-2-methylene-22-dehydro-1alpha,24,25-trihydroxy-19-nor-vitamin D3 Analogs App 20140206655 - DeLuca; Hector F. ; et al.	2014-07-24
A-ring modified 19-nor-vitamin D analogs and their uses Grant 8,785,422 - DeLuca , et al. July 22, 2	2014-07-22
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism App 20140187522 - DeLuca; Hector F. ; et al.	2014-07-03
Once-a-week administration of 25-hydroxy vitamin D.sub.3 to sustain elevated steady-state pharmacokinetic blood concentration Grant 8,759,328 - Deluca , et al. June 24, 2	2014-06-24
22-haloacetoxy-homopregnacalciferol analogs and their uses Grant 8,754,067 - DeLuca , et al. June 17, 2	2014-06-17
3-desoxy-2-methylene-vitamin D analogs and their uses Grant 8,729,054 - DeLuca , et al. May 20, 2	2014-05-20
Once-a-week Administration Of 25-hydroxy Vitamin D3 To Sustain Elevated Steady-state Pharmacokinetic Blood Concentration App 20140100203 - DeLuca; Hector F. ; et al.	2014-04-10
Diastereomers of 2-methylene-19-nor-22-methyl-1.alpha.,25-dihydroxyvitamin D.sub.3 Grant 8,664,206 - DeLuca , et al. March 4, 2	2014-03-04
1-desoxy-2-methylene-19-nor-vitamin D analogs and their uses Grant 8,642,579 - DeLuca , et al. February 4, 2	2014-02-04
Methods Of Use To Orally And Topically Treat Acne And Other Skin Conditions By Administering A 19-nor Containing Vitamin D Analog With Or Without A Retinoid App 20140018332 - Clagett-Dame; Margaret ; et al.	2014-01-16
2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin D3 App 20140011778 - DeLUCA; Hector F. ; et al.	2014-01-09
Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism App 20140005152 - DeLuca; Hector F. ; et al.	2014-01-02
2.alpha.-methyl and 2.beta.-methyl analogs of 19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and their uses Grant 8,614,202 - DeLuca , et al. December 24, 2	2013-12-24
2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs Grant 8,609,643 - DeLuca , et al. December 17, 2	2013-12-17
A-Ring Modified 19-Nor-Vitamin D Analogs and Their Uses App 20130331459 - DeLuca; Hector F. ; et al.	2013-12-12
2-methylene-19,21-dinor-1.alpha.-hydroxy-bishomopregnacalciferol Grant 8,604,008 - DeLuca , et al. December 10, 2	2013-12-10
(20S)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-dihydroxyvitamin D.sub.3 and (20R)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-hydroxyvitamin D.sub.3 Grant 8,604,009 - DeLuca , et al. December 10, 2	2013-12-10
Crystallization of (20R,22R)-2-Methylene-19-Nor-22-Methyl-1alpha,25-Dihydroxyvitamin D3 and Related Precursors App 20130324752 - DeLuca; Hector F. ; et al.	2013-12-05
2-methylene-1.alpha.-hydroxy-18,19,21-trinorvitamin D.sub.3 analogs and uses thereof Grant 8,575,136 - DeLuca , et al. November 5, 2	2013-11-05
2-methylene-19-nor-vitamin D analogs and their uses Grant 8,518,917 - DeLuca , et al. August 27, 2	2013-08-27
2-Methylene-20(21)-Dehydro-19,24,25,26,27-Pentanor-Vitamin D Analogs App 20130178449 - DeLuca; Hector F. ; et al.	2013-07-11
2-methylene-vitamin D analogs and their uses Grant 8,455,467 - DeLuca , et al. June 4, 2	2013-06-04
(20S,22E)-2-methylene-19-nor-22-ene-1.alpha.,25-dihydroxyvitamin D.sub.3 Grant 8,445,468 - DeLuca , et al. May 21, 2	2013-05-21
2.alpha.-methyl and 2.beta.-methyl analogs of 19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and their uses Grant 8,440,647 - DeLuca , et al. May 14, 2	2013-05-14
2-methylene-vitamin D Analogs And Their Uses App 20130102573 - DeLuca; Hector F. ; et al.	2013-04-25
3-Desoxy-2-Methylene-Vitamin D Analogs and Their Uses App 20130102567 - DeLuca; Hector F. ; et al.	2013-04-25
2-methylene-vitamin D Analogs And Their Uses App 20130102574 - DeLuca; Hector F. ; et al.	2013-04-25
2-methylene-vitamin D analogs and their uses Grant 8,410,080 - DeLuca , et al. April 2, 2	2013-04-02
2-substituted-1.alpha.,25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof Grant 8,404,666 - DeLuca , et al. March 26, 2	2013-03-26
Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog Grant 8,404,667 - Clagett-Dame , et al. March 26, 2	2013-03-26
2.alpha.-methyl-19-nor-1.alpha.-hydroxy-homopregnacalciferol and its uses Grant 8,399,438 - DeLuca , et al. March 19, 2	2013-03-19
2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs Grant 8,399,439 - DeLuca , et al. March 19, 2	2013-03-19
2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin D3 App 20130053356 - DELUCA; Hector F. ; et al.	2013-02-28
2Alpha-Methyl and 2Beta-Methyl Analogs of 19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Their Uses App 20130018021 - DeLuca; Hector F. ; et al.	2013-01-17
2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs App 20130005686 - DeLuca; Hector F. ; et al.	2013-01-03
3-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses App 20120322775 - DeLuca; Hector F. ; et al.	2012-12-20
2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses App 20120283228 - DeLuca; Hector F. ; et al.	2012-11-08
(20S)-24-(p-Toluenesulfonyloxy)-25,26,27-Trinorvitamin D3 Analogs and Their Uses App 20120283227 - DeLuca; Hector F. ; et al.	2012-11-08
17,20(Z)-dehydro vitamin D analogs and their uses Grant 8,232,263 - DeLuca , et al. July 31, 2	2012-07-31
2-methylene-19-nor-(20R)-1.alpha.-hydroxy-bishomopregnacalciferol Grant 8,222,235 - DeLuca , et al. July 17, 2	2012-07-17
2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs Grant 8,222,236 - DeLuca , et al. July 17, 2	2012-07-17
19-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring Grant 8,217,023 - DeLuca , et al. July 10, 2	2012-07-10
Diastereomers Of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin D3 App 20120165300 - DeLUCA; Hector F. ; et al.	2012-06-28
2-Methylene-19-Nor-Vitamin D Analogs and Their Uses App 20120157418 - DeLuca; Hector F. ; et al.	2012-06-21
22-Haloacetoxy-Homopregnacalciferol Analogs and Their Uses App 20120149669 - DeLuca; Hector F. ; et al.	2012-06-14
2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs Grant 8,193,170 - DeLuca , et al. June 5, 2	2012-06-05
(20R)-2.alpha.-methyl-19,26,2-trinor-vitamin D analogs Grant 8,193,169 - DeLuca , et al. June 5, 2	2012-06-05
13,13-dimethyl-des-C,D analogs of 1.alpha.,25-dihydroxy-19-nor-vitamin D.sub.3 compounds and topical composition dosage forms and methods of treating skin conditions thereof Grant 8,193,171 - DeLuca , et al. June 5, 2	2012-06-05
6-methylvitamin D.sub.3 analogs and their uses Grant 8,178,517 - DeLuca , et al. May 15, 2	2012-05-15
Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin D compound Grant 8,143,238 - DeLuca , et al. March 27, 2	2012-03-27
2alpha-Methyl-19-Nor-(20S)-1alpha-Hydroxy-Bishomopregnacalciferol and Its Uses App 20120071562 - DeLuca; Hector F. ; et al.	2012-03-22
2-methylene-(20S,25S)-19,27-dinor-(22E)-vitamin D analogs Grant 8,114,859 - DeLuca , et al. February 14, 2	2012-02-14
2.alpha.-methyl-19-nor-(20S)-1.alpha.-hydroxy-bishomopregnacalciferol and its uses Grant 8,093,232 - DeLuca , et al. January 10, 2	2012-01-10
2-METHYLENE-19,26-NOR-(20S)-1alpha-HYDROXYVITAMIN D3 App 20110294764 - DeLuca; Hector F. ; et al.	2011-12-01
1a-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereof Grant 8,058,265 - Deluca , et al. November 15, 2	2011-11-15
19,26,27-trinor-1.alpha.,25-dihydroxyvitamin D.sub.3 compounds Grant 8,030,295 - DeLuca , et al. October 4, 2	2011-10-04
Diastereomers Of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin D3 App 20110237557 - DeLuca; Hector F. ; et al.	2011-09-29
(20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22-DIMETHYL-1alpha,25-HYDROXYVITAMIN D3 App 20110237556 - DeLuca; Hector F. ; et al.	2011-09-29
Methods of Use To Orally and Topically Treat Acne and Other Skin Conditions By Administering a 19-NOR Containing Vitamin D Analog With or Without a Retinoid App 20110195941 - Clagett-Dame; Margaret ; et al.	2011-08-11
2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs Grant 7,947,666 - DeLuca , et al. May 24, 2	2011-05-24
2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogs Grant 7,943,601 - DeLuca , et al. May 17, 2	2011-05-17
(20S,22E)-2-Methylene-19-Nor-22-Ene-1Alpha,25-Dihydroxyvitamin D3 App 20110086824 - DeLuca; Hector F. ; et al.	2011-04-14
19-Nor-Vitamin D Analogs With 1,2- or 3,2-Cyclopentene Ring App 20110082122 - DeLuca; Hector F. ; et al.	2011-04-07
6-Methylvitamin D3 Analogs and Their Uses App 20110082123 - DeLuca; Hector F. ; et al.	2011-04-07
1-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses App 20110082121 - DeLuca; Hector F. ; et al.	2011-04-07
Vitamin D receptor antagonists and their use in treating asthma Grant 7,915,242 - DeLuca , et al. March 29, 2	2011-03-29
2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs Grant 7,893,043 - DeLuca , et al. February 22, 2	2011-02-22
2-methylene-20(21)-dehydro-19-nor-vitamin D analogs Grant 7,888,339 - DeLuca , et al. February 15, 2	2011-02-15
19-nor-vitamin D analogs with 1,2-dihydrofuran ring Grant 7,879,829 - DeLuca , et al. February 1, 2	2011-02-01
Vitamin D analog--RAK, methods and uses thereof Grant 7,803,789 - Deluca , et al. September 28, 2	2010-09-28
(20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses Grant RE41,491 - DeLuca , et al. August 10, 2	2010-08-10
(20S)-1.alpha.-Hydroxy-2-Methylene-19-Nor-Bishomopregnacalciferol and its uses Grant RE41,474 - DeLuca , et al. August 3, 2	2010-08-03
1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds with a 1,1-dimethylpropyl side chain Grant 7,763,598 - DeLuca , et al. July 27, 2	2010-07-27
2-Alkylidene-18,19-Dinor-Vitamin D Compounds App 20100179344 - DeLuca; Hector F. ; et al.	2010-07-15
2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs Grant 7,741,314 - DeLuca , et al. June 22, 2	2010-06-22
17,20(E)-dehydro vitamin D analogs and their uses Grant 7,741,313 - DeLuca , et al. June 22, 2	2010-06-22
(20R)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs Grant 7,718,638 - DeLuca , et al. May 18, 2	2010-05-18
(20S)-23,23-difluoro-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs Grant 7,718,637 - DeLuca , et al. May 18, 2	2010-05-18
Use of 2-methylene-19-nor-20(S)-1alpha,25dihydroxy vitamin d3 to inhibit mammary tumor Grant 7,718,636 - DeLuca , et al. May 18, 2	2010-05-18
2-methylene-19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D3 and its uses Grant 7,713,952 - DeLuca , et al. May 11, 2	2010-05-11
2-alkylidene-18,19-dinor-vitamin D compounds Grant 7,713,951 - DeLuca , et al. May 11, 2	2010-05-11
2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vit- amin D analogs Grant 7,713,953 - DeLuca , et al. May 11, 2	2010-05-11
2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses Grant 7,704,982 - DeLuca , et al. April 27, 2	2010-04-27
2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin D3 and uses thereof Grant 7,704,981 - DeLuca , et al. April 27, 2	2010-04-27
2-methylene-1.alpha.-hydroxy-19,21-dinorvitamin D.sub.3 analogs and uses thereof Grant 7,648,972 - DeLuca , et al. January 19, 2	2010-01-19
19-nor-vitamin D analogs with 3,2-dihydrofuran ring Grant 7,648,974 - DeLuca , et al. January 19, 2	2010-01-19
2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin D.sub.3 analogs and uses thereof Grant 7,648,973 - DeLuca , et al. January 19, 2	2010-01-19
19-nor-vitamin D Analogs With 3,2-dihydrofuran Ring App 20100009945 - DeLuca; Hector F. ; et al.	2010-01-14
2-Methylene-(22E)-25-(1-Methylene-Hexyl)-26,27-Cyclo-22-Dehydro-19-Nor-Vit- amin D Analogs App 20100009943 - DeLuca; Hector F. ; et al.	2010-01-14
2-Methylene-(20E)-20(22)-Dehydro-19-Nor-Vitamin D Analogs App 20100009940 - DeLuca; Hector F. ; et al.	2010-01-14
2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs App 20100009947 - DeLuca; Hector F. ; et al.	2010-01-14
2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs App 20100009941 - DeLuca; Hector F. ; et al.	2010-01-14
19-Nor-Vitamin D Analogs with 1,2-Dihydrofuran Ring App 20100009944 - DeLuca; Hector F. ; et al.	2010-01-14
2-Methylene-19,26-Dinor-(20R,22E,25R)-Vitamin D Analogs App 20100009946 - DeLuca; Hector F. ; et al.	2010-01-14
2-Methylene-(17Z)-17(20)-Dehydro-19,21-Dinor-Vitamin D Analogs App 20100009942 - DeLuca; Hector F. ; et al.	2010-01-14
1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D Compounds And Methods Of Making And Treatment Thereof App 20090281340 - DeLuca; Hector F. ; et al.	2009-11-12
Methods Of Increasing Epidermal Skin Thickness By Topical Administration Of A 19-nor Containing Vitamin D Compound App 20090227545 - DeLuca; Hector F. ; et al.	2009-09-10
13,13-Dimethyl-des-C,D Analogs of 1Alpha,25-Dihydroxy-19-Nor-Vitamin D3 Compounds and Topical Composition Dosage Forms and Methods of Treating Skin Conditions Thereof App 20090186950 - DeLuca; Hector F. ; et al.	2009-07-23
2-methylene-19-nor-(20S-24S)-1.alpha.,25-dihydroxyvitamin-D.sub.2 Grant 7,563,783 - DeLuca , et al. July 21, 2	2009-07-21
(20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs App 20090170819 - DeLuca; Hector F. ; et al.	2009-07-02
2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs App 20090170822 - DeLuca; Hector F. ; et al.	2009-07-02
2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs App 20090170820 - DeLuca; Hector F. ; et al.	2009-07-02
(20S)-23,23-Difluoro-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs App 20090170818 - DeLuca; Hector F. ; et al.	2009-07-02
2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs App 20090170821 - DeLuca; Hector F. ; et al.	2009-07-02
2-methylene-19-nor-(20S)-1.alpha.-hydroxy-trishomopregnacalciferol Grant 7,541,348 - DeLuca , et al. June 2, 2	2009-06-02
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone Grant 7,541,349 - DeLuca , et al. June 2, 2	2009-06-02
19-nor-vitamin D analogs with 1,2 or 3,2 heterocyclic ring Grant 7,538,098 - DeLuca , et al. May 26, 2	2009-05-26
(20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses Grant 7,534,778 - DeLuca , et al. May 19, 2	2009-05-19
Des-C,D analogs of 1.alpha.,25-dihydroxy-19-norvitamin D.sub.3 Grant 7,534,777 - DeLuca , et al. May 19, 2	2009-05-19
2-Propylidene-19-nor-vitamin D compounds Grant 7,531,527 - DeLuca , et al. May 12, 2	2009-05-12
Vitamin D analog--NEL, methods and uses thereof Grant 7,528,122 - DeLuca , et al. May 5, 2	2009-05-05
2-methylene-19-nor-(20S-24epi)-1.alpha.,25-dihydroxyvitamin D.sub.2 Grant 7,511,030 - DeLuca , et al. March 31, 2	2009-03-31
(20R)-2a-Methyl-19,26,27-Trinor-Vitamin D Analogs App 20080300223 - DeLuca; Hector F. ; et al.	2008-12-04
Compounds, Compositions, Kits And Methods Of Use To Orally And Topically Treat Acne And Other Skin Conditions By Administering A 19-nor Containing Vitamin D Analog With Or Without A Retinoid App 20080261925 - Clagett-Dame; Margaret ; et al.	2008-10-23
Method of Extending the Dose Range of Vitamin D Compounds App 20080249068 - DeLuca; Hector F. ; et al.	2008-10-09
(20S)-1Alpha-Hydroxy-2-Methylene-19-Nor-Bishomopregnacalciferol and Its Uses App 20080096851 - DeLuca; Hector F. ; et al.	2008-04-24
2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs App 20080081799 - DeLuca; Hector F. ; et al.	2008-04-03
2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs App 20080081800 - DeLuca; Hector F. ; et al.	2008-04-03
Pulmonary delivery of 1alpha,25-dihydroxyvitamin D3 and co-administration of parathyroid hormone or calcitonin App 20080031957 - DeLuca; Hector F. ; et al.	2008-02-07
2Alpha-Methyl and 2Beta-Methyl Analogs of 19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Their Uses App 20070270391 - DeLuca; Hector F. ; et al.	2007-11-22
17,20(Z)-Dehydro Vitamin D Analogs and Their Uses App 20070259838 - DeLuca; Hector F. ; et al.	2007-11-08
2-methylene-19-nor-(23s)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone And 2-methylene-19-nor-(23r)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone App 20070259953 - DeLuca; Hector F. ; et al.	2007-11-08
2Alpha-Methyl-19-Nor-(20S)-1Alpha-Hydroxy-Bishomopregnacalciferol and Its Uses App 20070254857 - DeLuca; Hector F. ; et al.	2007-11-01
17,20(E)-dehydro vitamin D analogs and their uses App 20070249568 - DeLuca; Hector F. ; et al.	2007-10-25
2-Methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses App 20070249569 - DeLuca; Hector F. ; et al.	2007-10-25
2-Methylene-19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Its Uses App 20070249567 - DeLuca; Hector F. ; et al.	2007-10-25
1a-Hydroxy-2-(3'-Hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereof App 20070244072 - Deluca; Hector F. ; et al.	2007-10-18
2-Methylene-1Alpha,25-Dihydroxy-18,19,21-Trinorvitamin D3 and Uses Thereof App 20070238705 - DeLuca; Hector F. ; et al.	2007-10-11
19-Nor-Vitamin D Analogs with 1,2 or 3,2 Heterocyclic Ring App 20070238712 - DeLuca; Hector F. ; et al.	2007-10-11
1alpha-Hydroxy-2-(3'-Hydroxypropylidene)-19-Nor-Vitamin D Compounds with a 1,1-Dimethylpropyl Side Chain App 20070238703 - DeLuca; Hector F. ; et al.	2007-10-11
2-Methylene-1alpha-Hydroxy-18,19,21-Trinorvitamin D3 Analogs and Uses Thereof App 20070238701 - DeLuca; Hector F. ; et al.	2007-10-11
2-Methylene-1Alpha,25-Dihydroxy-19,21-Dinorvitamin D3 Analogs and Uses Thereof App 20070238706 - DeLuca; Hector F. ; et al.	2007-10-11
2-Substituted-1Alpha,25-Dihydroxy-19,26,27-Trinor Vitamin D Analogs and Uses Thereof App 20070238704 - DeLuca; Hector F. ; et al.	2007-10-11
2-Methylene-1Alpha-Hydroxy-19,21-Dinorvitamin D3 Analogs and Uses Thereof App 20070238702 - DeLuca; Hector F. ; et al.	2007-10-11
19,26,27-TRINOR-1alpha,25-DIHYDROXYVITAMIN D3 COMPOUNDS App 20070219168 - DeLuca; Hector F. ; et al.	2007-09-20
2-Propylidene-19-nor-vitamin D compounds App 20070213546 - DeLuca; Hector F. ; et al.	2007-09-13
Method of extending the dose range of vitamin D compounds Grant 7,259,143 - DeLuca , et al. August 21, 2	2007-08-21
Vitamin D Analog - Nel, Methods And Uses Thereof App 20070191316 - DELUCA; Hector F. ; et al.	2007-08-16
Vitamin D Analog - Rak, Methods And Uses Thereof App 20070191317 - DELUCA; Hector F. ; et al.	2007-08-16
2-methylene-19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and its uses Grant 7,244,719 - DeLuca , et al. July 17, 2	2007-07-17
2-propylidene-19-nor-vitamin D compounds Grant 7,241,747 - DeLuca , et al. July 10, 2	2007-07-10
2-methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses Grant 7,241,750 - DeLuca , et al. July 10, 2	2007-07-10
19,26,27-trinor-1.alpha.,25-dihydroxyvitamin D.sub.3 compounds Grant 7,241,909 - DeLuca , et al. July 10, 2	2007-07-10
17,20(E)-dehydro vitamin D analogs and their uses Grant 7,241,752 - DeLuca , et al. July 10, 2	2007-07-10
2.alpha.-Methyl and 2.beta.-methyl analogs of 19,26,27-trinor-(20S)-1.alpha.-hydroxyvitamin D.sub.3 and their uses Grant 7,241,749 - DeLuca , et al. July 10, 2	2007-07-10
17,20(Z)-dehydro vitamin D analogs and their uses Grant 7,241,748 - DeLuca , et al. July 10, 2	2007-07-10
2.alpha.-methyl-19-nor-(20S)-1.alpha.-hydroxy-bishomopregnacalciferol and its uses Grant 7,241,751 - DeLuca , et al. July 10, 2	2007-07-10
2-Methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses Grant 7,238,681 - DeLuca , et al. July 3, 2	2007-07-03
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone Grant 7,235,680 - DeLuca , et al. June 26, 2	2007-06-26
Des-C,D analogs of 1alpha,25-dihydroxy-19-norvitamin D3 App 20070112077 - DeLuca; Hector F. ; et al.	2007-05-17
Use of 2-methylene-19-nor-20(S)-1.alpha.,25-dihydroxyvitamin D.sub.3 to increase the life expectancy of human beings Grant 7,214,670 - DeLuca , et al. May 8, 2	2007-05-08
Use of 2-methylene-19-nor-20(S)-1.alpha.,25-dihydroxyvitamin D.sub.3 for the prophylaxis of bone diseases Grant 7,214,671 - DeLuca , et al. May 8, 2	2007-05-08
19,23,24,25,26,27-Hexanor-1alpha-hydroxyvitamin D3 App 20070066566 - DeLuca; Hector F. ; et al.	2007-03-22
2-Propylidene-19-nor-vitamin d compounds App 20060293291 - DeLuca; HectorF ; et al.	2006-12-28
19,26,27-trinor-1alpha,25-dihydroxyvitamin D3 compounds App 20060264410 - DeLuca; Hector F. ; et al.	2006-11-23
Use of 2-methylene-19-nor-20(S)-1alpha,25dihydroxyvitamin D3 to increase the life expectancy of human beings App 20060241090 - DeLuca; Hector F. ; et al.	2006-10-26
2-Methylene-19-nor-(23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone App 20060223782 - DeLuca; Hector F. ; et al.	2006-10-05
2-Methylene-19-nor-(20S-24epi)-1alpha,25-dihydroxyvitamin D2 App 20060183721 - DeLuca; Hector F. ; et al.	2006-08-17
2-Methylene-19-nor-(20S-24S)-1alpha,25-dihydroxyvitamin D2 App 20060183716 - DeLuca; Hector F. ; et al.	2006-08-17
2alpha-methyl-19-nor-(20S)-1alpha-hydroxy-bishomopregnacalciferol and its uses App 20060160769 - DeLuca; Hector F. ; et al.	2006-07-20
2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses App 20060148759 - DeLuca; Hector F. ; et al.	2006-07-06
2-Methylene-19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and its uses App 20060142246 - DeLuca; Hector F. ; et al.	2006-06-29
2-Methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol App 20060135800 - DeLuca; Hector F. ; et al.	2006-06-22
2-Methylene-19-NOR-(20R)-1alpha-hydroxy-bishomopregnacalciferol App 20060135799 - DeLuca; Hector F. ; et al.	2006-06-22
2-Methylene-19-nor-(20S)-1alpha-hydroxy-trishomopregnacalciferol App 20060135798 - DeLuca; Hector F. ; et al.	2006-06-22
2-Methylene-18,19-dinor-1alpha-hydroxy-homopregnacalciferol and its uses App 20060122157 - DeLuca; Hector F. ; et al.	2006-06-08
17,20(Z)-dehydro vitamin D analogs and their uses App 20060116351 - DeLuca; Hector F. ; et al.	2006-06-01
2alpha-Methyl and 2beta-methyl analogs of 19,26,27-trinor-(20S)-1alpha-hydroxyvitamin D3 and their uses App 20060116352 - DeLuca; Hector F. ; et al.	2006-06-01
Methods for reducing body fat using vitamin D compounds Grant 7,053,075 - DeLuca , et al. May 30, 2	2006-05-30
2-Methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses App 20060111321 - DeLuca; Hector F. ; et al.	2006-05-25
17,20(E)-dehydro vitamin D analogs and their uses App 20060111330 - DeLuca; Hector F. ; et al.	2006-05-25
2-alkylidene-18,19-dinor-vitamin D compounds App 20050227950 - DeLuca, Hector F. ; et al.	2005-10-13
Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases App 20050187201 - DeLuca, Hector F. ; et al.	2005-08-25
Vitamin D receptor antagonists and their use in treating asthma App 20050182033 - DeLuca, Hector F. ; et al.	2005-08-18
Methods for reducing body fat using vitamin D compounds App 20050143358 - DeLuca, Hector F. ; et al.	2005-06-30
(20S)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses App 20050096300 - DeLuca, Hector F. ; et al.	2005-05-05
(20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses Grant 6,887,860 - DeLuca , et al. May 3, 2	2005-05-03
Use of 2-Methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase the life expectancy of human beings App 20050065123 - DeLuca, Hector F. ; et al.	2005-03-24
2-Propylidene-19-nor-vitamin D compounds App 20040229851 - DeLuca, Hector F. ; et al.	2004-11-18
Method of extending the dose range of vitamin D compounds App 20040053813 - DeLuca, Hector F. ; et al.	2004-03-18
(20S)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses App 20040033998 - DeLuca, Hector F. ; et al.	2004-02-19
(20S)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses Grant 6,627,622 - DeLuca , et al. September 30, 2	2003-09-30
(20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol And Its Uses App 20030158157 - DeLuca, Hector F. ; et al.	2003-08-21
1 .alpha.-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses Grant 6,566,352 - DeLuca , et al. May 20, 2	2003-05-20
1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses App 20020183289 - DeLuca, Hector F. ; et al.	2002-12-05
1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses App 20020052350 - DeLuca, Hector F. ; et al.	2002-05-02